The cyclic GMP-AMP (cGAMP) synthase cGAS counteracts infections by detecting and binding foreign cytoplasmic DNA 1 . DNA-induced synthesis of cGAMP activates innate immune signalling and apoptosis through the cGAMP receptor STING and the downstream effector IRF3 1-7 . During interphase the nuclear envelope protects chromosomal self-DNA from cGAS, but the consequences of exposing chromosomes to cGAS following mitotic nuclear envelope disassembly are unknown. Here we demonstrate that cGAS associates with chromosomes during mitosis and binds nucleosomes with even higher affinity than naked DNA in vitro. Nucleosomes nevertheless competitively inhibit the DNA-dependent stimulation of cGAS, and accordingly, chromosomal cGAS does not affect mitotic progression under normal conditions. This suggests that nucleosomes prevent the inappropriate activation of cGAS during mitosis by acting as a signature of self-DNA. During prolonged mitotic arrest, however, cGAS becomes activated to promote cell death, limiting the fraction of cells that can survive and escape mitotic arrest induced by the chemotherapeutic drug taxol. Induction of mitotic cell death involves cGAMP synthesis by cGAS, as well as signal transduction to IRF3 by STING. We thus propose that 2 cGAS plays a previously unappreciated role in guarding against mitotic errors, promoting cell death during prolonged mitotic arrest. Our data also indicate that the cGAS pathway, whose activity differs widely among cell lines, impacts cell fate determination upon treatment with taxol and other anti-mitotic drugs. Thus, we propose the innate immune system may be harnessed to selectively target cells with mitotic abnormalities.
3 cGAS binding (Extended Data Fig. 1 ). Gel-shift assays of recombinant cGAS (Extended Data Fig. 2 ) further demonstrated that cGAS has ~2-fold higher affinity for mononucleosomes than for naked DNA (Fig. 1b, c) . Mutations in the cGAS DNA-binding interface 15 (K173E R176E K407E K411A) greatly reduced affinity for naked DNA, while affecting nucleosome interaction only modestly (Fig. 1d, e ), suggesting that mechanisms of cGAS binding to naked DNA and to nucleosomes are distinct.
Despite the enhanced affinity for cGAS, we found that nucleosomes suppress the cGAMP synthase activity of cGAS. When compared to DNA-bound cGAS, nucleosome-bound cGAS showed a ~3-fold reduction in the apparent catalysis rate (Kcat), as determined by thin-layer chromatography of reactions under saturating conditions of mononucleosomes or naked DNA ( Fig. 2a-c) . Consistent with the idea that nucleosomes could competitively suppress the capacity of naked DNA to activate cGAS, nucleosomes added to standard reactions containing saturating amounts of naked DNA decreased the apparent Kcat in a manner proportional to the concentration of nucleosomes ( Fig. 2d ). Altogether, these results suggest that, on chromosomes, nucleosomes could competitively interfere with cGAS activation by nucleosome-free regions.
Given our findings that cGAS binds nucleosomes, we speculated that cGAS can freely associate with chromosomes when they are exposed to the cytoplasm. Indeed, similar to a recent report in mouse cells 16 , immunofluorescence analysis demonstrated that cGAS associates with mitotic chromosomes in HeLa cells and in telomerase-immortalized human BJ hTERT fibroblasts ( Fig. 2e-g) , both during unperturbed mitosis, and during mitotic arrest induced with the chemotherapeutic microtubule-stabilizing drug taxol (paclitaxel). This signal was specific, as it was not observed after siRNA-mediated knockdown of cGAS (Extended Data Fig. 3a, b ).
Live-imaging of GFP-tagged cGAS (GFP-cGAS) in HeLa Flp-In T-REx cells 17, 18 , expressing inducible GFP-cGAS from a single genomic locus, showed that cGAS associates with chromosomes immediately after nuclear envelope break down (Extended Data Fig. 3c ). In contrast, cGAS was largely absent from interphase nuclei, with the exception of a subset of micronuclei (Extended Data Fig. 3d , e), structures whose nuclear envelopes are prone to rupture 19, 20 .
To determine whether chromosome-bound cGAS could activate the STING pathway during mitosis, we monitored mitotic IRF3 phosphorylation at Ser396 (IRF3ph), a widely used indicator of cGAS activation, in cells arrested in mitosis using taxol. In agreement with the limited cGAS activity on nucleosomes, we found little evidence for IRF3ph on the endogenous protein ( Fig.   2h ), but mild overexpression of GFP-tagged IRF3 revealed a slow cGAS-dependent increase in IRF3ph during mitotic arrest, but not in interphase ( Fig. 2h ).
As nucleosomes limit DNA-dependent cGAS activity, cGAS binding to chromosomes may not have consequences during normal mitosis, which completes within an hour, whereas cGAS signalling occurs over multiple hours 4 (Fig. 2h ). Indeed, we found that cGAS depletion neither affected viability or duration of unperturbed mitosis (Extended Data Fig. 4a, b ). However, when cells are arrested in mitosis, even low cGAS activity may have functional consequences. Cells arrested in mitosis stochastically undergo one of two fates, death in mitosis or slippage into interphase. The timing of these events differs substantially between cells, and cell fate profiles also vary widely between cell lines 21 . The decision between death and slippage may carry particular weight when tumour cells undergo anti-mitotic chemotherapy, such as taxol. However, the mechanisms underlying the variation in this fate decision are poorly understood 22, 23 . Because cGAS protein levels vary drastically among cell lines (Extended Data Fig. 5a ), and the cGAS pathway may induce apoptosis independently of transcriptional induction 2,3,7,24 , we tested whether cGAS affects the decision between slippage and death.
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We first treated seven breast cancer cell lines (Extended Data Fig. 5a ) with a clinically relevant taxol concentration (10 nM) 25, 26 . All three cell lines (CAL51, T47D, BT474) that did not express cGAS were able to survive mitotic arrest under this condition, whereas three out of four cell lines expressing cGAS (HCC1143, MDA-MB-157, BT549) were prone to die in mitosis (Extended Data Fig. 5b ). Similar effects were observed with a high taxol dose (0.5 µM;
Extended Data Fig. 5c ). No difference in mitotic viability was observed in the absence of taxol, suggesting that the observed cell death depends on mitotic arrest (Extended Data Fig. 5d ).
siRNA-mediated depletion of cGAS reduced mitotic mortality by ~50% in the three most sensitive cell lines (Extended Data Fig. 5e , f), further suggesting an involvement of cGAS in the decision between death and slippage in these breast cancer cells.
To characterise the mechanism by which cGAS promotes mitotic death in detail, we focussed on two cell lines, HeLa Flp-In T-REx cell lines, which were used to inducibly express siRNAresistant, wild type, or mutant GFP-cGAS genes, and untransformed BJ-hTERT fibroblasts, which have been extensively used to analyse the cGAS-STING pathway 8, 27 . Similar to our observations in breast cancer cells, cGAS depletion resulted in a reduction in mitotic cell death in HeLa cells treated with 10 nM taxol ( Fig. 3a, b ). This effect could be a consequence of either enhancing the rate of slippage, or of a delay in the advent of cell death, thus giving cells more time to slip. To distinguish between these possibilities, we monitored the impact of cGAS depletion on the timing of cell death during taxol treatment. Because a change in slippage probability indirectly affects the apparent timing of mitotic cell death 28 , slippage events were blocked by using a higher concentration of taxol (500 nM) in conjunction with the anaphasepromoting complex inhibitor proTAME 29 . This setup, combined with time-lapse microscopy, allowed us to determine individual mitotic lifespans, solely dictated by the timing of death, but not by slippage. mediated disruptions of cGAS generated with two different short guide RNAs showed phenotypes identical to cGAS knockdown ( Fig. 3e, f) . The extension of mitotic lifespan by cGAS depletion in HeLa cells was comparable to the effect observed upon inhibition of apoptosis with the caspase inhibitor Z-VAD-FMK (Extended Data Fig. 6a ). cGAS depletion also greatly extended mitotic lifespan in another HeLa cell line (CCL-2), which had an overall longer mitotic lifespan than the HeLa Flp-In T-REx line (Extended Data Fig. 6b ). In contrast, ARPE-19 hTERT retinal pigment epithelium cells, which express very little cGAS ( Fig. 3a ), tolerated mitotic arrest extremely well, surviving extensive arrest (30 -40 h) , and cGAS siRNA treatment did not have any impact on mitotic lifespan (Fig. 3j ).
The extended lifespan in taxol was not due to off-target effects, as expression of siRNA resistant wild type cGAS (GFP-cGAS wt ) fully restored shorter lifespans in sicGAS cells ( Fig. 3g ; Extended Data Fig. 6c ). Treatment with control siRNA by itself also did not affect timing of death (Extended Data Fig. 6d ). Promotion of mitotic cell death requires catalytic activity of cGAS since neither of two catalytic mutants, GFP-cGAS cat (E225A D227A), mutated in the catalytic pocket, or GFP-cGAS DNA (K407E K411A), in which DNA binding does not induce the conformational changes required for catalysis 15 , rescued cGAS depletion ( Fig. 3g ; Extended Data Fig. 6c ). cGAS does not appear to be a general death accelerator, as its depletion did not affect timing of death after UV irradiation (Extended Data Fig. 7a, b ). Altogether, these results indicate that cGAS promotes death during mitotic arrest.
If cGAS promotes death through cGAMP, cGAMP addition should substitute for cGAS and reduce mitotic lifespan. In both HeLa and BJ-hTERT cells depleted for cGAS, this was indeed 7 the case ( Fig. 4a, b ). However, cGAMP treated cells did not die as fast as controls, most likely due to incomplete intracellular cGAMP delivery. In previous studies investigating cGAMP induction of interferon transcription, membrane transversal was promoted by transfection agents 27 or chemical membrane permeabilisation 5, 30 . These treatments are cytotoxic, and are therefore not appropriate for our assay. Regardless, our experiments show that cGAS, at least in part through cGAMP, induces mitotic death in both untransformed and transformed cells.
cGAMP-treatment does not appear to induce cell death by a nonspecific mechanism, since cGAMP addition or ectopic cGAS expression in ARPE-19 hTERT cells, which hardly express cGAS ( Fig. 3a ), had only modest effects on mitotic death (Extended Data Fig. 8a -c). Despite the presence of the cGAMP acceptor STING (Extended Data Fig. 5a ), ARPE-19 hTERT cells appear to be defective further downstream in the pathway, as cGAMP addition could not induce IRF3ph (Extended Data Fig. 8d ). Altogether, these observations suggest that cGAMP signalling, but not unspecific cGAMP toxicity, promotes mitotic cell death.
Since the major known consequence of cGAS activation is stimulation of transcription factors, such as IRF3, we wondered how cGAS stimulates cell death in mitosis, where transcription is generally shut off 31 . Indeed, interferon beta, the classical IRF3 target 1 was not induced during mitosis in BJ-hTERT cells, whilst DNA transfection in asynchronous cells effectively stimulated its transcription ( Fig. 4c ). Furthermore, treatment of cells with the transcription inhibitor triptolide 32 did not extend mitotic lifespan ( Fig. 4d ). However, IRF3 can also induce apoptosis independently of transcription by mediating the mitochondrial translocation of Bax 2 , a protein that induces outer mitochondrial membrane permeabilisation, a critical step for apoptosis in mitosis 22, 23, 33 . In agreement with the requirement for signalling to IRF3 in the transcription-independent induction of apoptosis, CRISPR-Cas9 mediated disruption of either STING or IRF3 extended mitotic lifespan similarly to cGAS depletion ( Fig. 4e , f).
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Thus, our data show that cGAS induces mitotic cell death through cGAS signalling, but independently of transcription.
Here we demonstrated that cGAS signalling is limited by nucleosomes, suppressing cGAS pathway activation during normal mitosis. However, during defective mitosis, cGAS can be utilised to sense the prolonged exposure of chromosomes to the cytoplasm, promoting cell death.
Alternatively, cGAS may become activated by byproducts of extended mitotic arrest, such as mitochondrial permeabilisation 34 or DNA damage 35, 36 , although these events were seen at much later timing (>12 h) than the initial emergence of IRF3 phosphorylation (<1h, Fig. 2h ).
Ultimately, promotion of cell death by cGAS is likely to occur by stimulating mitochondrial relocalisation of IRF3, which in turn activates Bax-mediated apoptosis 2 . Rather than solely determining the timing of mitotic death, cGAS is likely to collaborate with other independent death factors operating on their own timers. These may include the mitosis-specific degradation of the pro-survival protein Mcl1, as well as transcriptional regulation of pro-apoptotic and prosurvival genes 22, 23 . As taxol prolongs mitosis, and also induces formation of micronuclei, where cGAS strongly accumulates, it is tempting to speculate that taxol efficacy may be altered by the functionality of the cGAS pathway. Induction of the intrinsic cell death pathway by mitotic defects may prevent the formation of aneuploidy, frequently associated with cellular senescence and cancer [37] [38] [39] . Activation of cGAS by multiple products of defective mitosis such as micronuclei, could also induce inflammation, which can affect tumour development and metastasis, as well as the immunological response to tumour development 40 . A detailed knowledge of cGAS function in the response to mitotic defects will be important for our understanding of tumour development and chemotherapy response.
Methods:
Antibodies and reagents. cGAS was detected with D1D3G (# 15102) from Cell Signaling Technology (1:500 dilution for western blot, 1:400 dilution for immunofluorescence); STING was detected with D2P2F (# 13647) from Cell Signaling Technology (1:500 dilution for western blotting); IRF3 (S396ph) was detected with # 4947 from Cell Signaling Technology (1:500 dilution for western blotting); IRF3 (total) was detected with ab68481 (abcam; 1:500 dilution for western blotting); α tubulin was detected with T9026 from Sigma (1:15000 dilution for western blotting). For western blotting, IRDye 800CW and 680LT secondary antibodies were used at 50 ng/ml and detected on an Odyssey infrared imaging system (LI-COR). For immunofluorescence microscopy, Alexa-488 and Alexa-555 coupled secondary antibodies were used (Jackson ImmunoResearch). cGAMP was obtained from Invivogen (tlrl-nacga23); doxycycline was obtained from Sigma (D9891); proTAME was obtained from Boston Biochem (I-440); RO3306 was obtained from Sigma (#SML-0569); SiR-DNA was obtained from Cytoskeleton (CY-SC007); taxol was obtained from Calbiochem (# 580555); thymidine was obtained from Sigma (T1895). Triptolide was obtained from Invivogen (# ant-tpl). HeLa Cell lines expressing GFP-tagged versions of cGAS or IRF3 were generated using plasmid pcDNA5/FRT/TO as a backbone following instructions based on the Flp-In system (Invitrogen). ARPE-19 hTERT cell lines expressing GFP-tagged versions of cGAS were generated using the piggyBac transposon system. cGAS cat represents the E225A D225A double mutant, cGAS DNA represents the K407E K411A double mutant, and the cGAS KKKR mutant is the K407E K411A K173E R176E quadruple mutant. Plasmid construction details are available on request. siRNA knockdowns were performed using the reverse transfection procedure. Briefly, siRNA was mixed with media without FBS (Opti-MEM, Life Technologies # 51985-034) and
Lipofectamine RNAiMAX (Invitrogen # 13778075) at an siRNA concentration of 120 nM (10 nM final concentration once cells and media were added). Lipofectamine RNAiMAX was added at 1.2 µl/ml of final volume. The mixture was incubated for 15 min, and cells were then added in media without antibiotics. Media was changed the next day.
For cell synchronizations, cells were pre-synchronized in S phase for 18 h with 2.5 mM thymidine. Cells were then washed twice in PBS and once in media, and cells were then released from the S phase arrest for 2 h in media without drugs. RO3306 (9 µM final) was then added to capture cells in G2. After 8-10 h, cells were washed twice with PBS, once with media containing 500 nM taxol before further incubation in media containing 500 nM taxol and 10 µM proTAME.
If BJ hTERT or ARPE-19 hTERT cells were prepared for time-lapse microscopy, SiR-DNA (125 nM final concentration) was added to the media 2 h before release from G2 arrest, and to the final media containing taxol and proTAME to allow for visualization of DNA. For induction of GFP-IRF3 or GFP-cGAS versions, doxycycline was added to a final concentration of 100 ng/ml ~24 h before release from G2 arrest.
If cells were prepared for time-lapse imaging, cells were subjected to siRNA knockdown at the same time as they were plated at ~30% confluence onto glass bottom culture dishes (MatTek P35GC-1.5-14-C). Cells were grown over night before addition of thymidine. To limit phototoxicity, the final imaging media did not contain phenol red.
DNA transfections to induce cGAS signalling. Cells were grown close to confluence on 6 cm dishes. Media was removed from cells and replaced with 2.4 ml of media containing no antibiotics. To generate the transfection mix, 7.5 µg of pAS696 41 
CRISPR-Cas9 mediated gene disruptions. Sequences encoding short guide RNAs (sgRNAs)
were cloned into pX330 42 , and transfected into cells. Cells were grown for five days, and then plated for single colonies. Multiple candidate clones were picked and tested for gene disruption by western blot. sgRNA sequences were as follows: cGAS sg#1: CTGCCCCCAAGGCTTCCGCA; For checking siRNA efficiency, cells treated identically to the cells that were used for microscopy, were harvested just before release into taxol.
Immunofluorescence microscopy. Cells were grown on coverslips coated in poly-D-lysine (Sigma P1024, coverslips were coated by incubation for ~30 min in a 1 mg/ml solution).
Coverslips were washed once in PBS, and subsequently cells were fixed with paraformaldehyde (Electron Microscopy Services # RT 157-8; 2% in PBS) by incubation for 20 min. Coverslips were washed three times in PBS and cells were then permeabilised for 5 min by incubation with PBS containing 0.2% Triton X-100 (Bio-Rad). Following three washes in PBS, coverslips were blocked in PBS-T (PBS plus 0.1% Tween-20 (Bio-Rad)) containing 5% BSA (Sigma A7906). Images were acquired with a 20 x objective every 15 min for 48-72 h, in some cases with multiple Z steps (~2 µM step sizes; ImageJ was used to generate sum projections when Z slices were taken). Individual cells were manually tracked using the CellCognition software 43 (v 1.5.2).
Timing of death or slippage into interphase were determined morphologically (slippage was defined by cell flattening, and initiation of death was defined by the characteristic morphological changes reminiscing of cell explosion). When cells expressing GFP-cGAS or its mutated versions, were used, only cells with similar levels of GFP-cGAS were analysed in order to compensate for expression level heterogeneity within the population.
UV-viability assays. Cells were seeded onto 6-well plates at ~20% confluence and allowed to attach for ~10 h. Cells were then washed twice in PBS and irradiated using an XL-1000
Spectrolinker UV crosslinker (Spectronics Corporation). Media was added and cells were grown under standard conditions. At the indicated time points, the supernatant (enriched for dead cells) was transferred to a tube and washed once in PBS, with the wash also moved to the same tube.
The remaining cells were trypsinised and also moved to the same tube. Cells were spun down, cGAS was purified using a modified version of published procedures 9 . Similar to previous work 8, 9, 44 , we generated cGAS lacking its N terminal (amino acids 1-150) unstructured tail. This truncation had previously been shown to be catalytically active 8, 9, 44 , and to fully substitute for full-length cGAS in interferon induction in response to cytoplasmic DNA 4 . We expressed this protein in E. coli with an N-terminal MBP tag and a C-terminal 10xHis tag, with the tags separated from the rest of the protein with TEV protease recognition sites. E. coli Rosetta 2 (DE3 pLysS) cells containing cGAS expression plasmids were grown in 1.5 x TBG-M9 medium (15 g/l tryptone; 7.5 g/l yeast extract; 5 g/l NaCl; 0.15 g/l MgSO 4 ; 1.5 g/l NH 4 Cl; 3 g/l KH 2 PO 4 ; 6 g/l 
Preparation of nucleosome arrays and mononucleosomes for binding assays. DNA
substrates used for nucleosome arrays and for their naked DNA counterparts were generated as described previously 13, 41 . Briefly, plasmid pAS696 containing 19 tandem copies of the "601" nucleosome-positioning sequence 45 was digested with HaeII, DraI, EcoRI and XbaI to remove the 601 array and to digest the vector backbone into smaller pieces. The array was then separated from the vector backbone fragments using PEG precipitation. To facilitate coupling to streptavidin beads, ends were filled in with Klenow fragment (NEB) in the presence of dCTP, biotin-14-dATP (Invitrogen), thio-dTTP and thio-dGTP (both Chemcyte). This resulted in biotinylation of both ends of the linear array. Arrays were separated from unincorporated nucleotides using Sephadex G-50 Nick columns (GE Healthcare).
To generate the DNA used for mononucleosomes or single copies of the naked 601 sequence, pAS696 was digested with AvaI (which cuts in between 601 monomers), and the fragment was separated from the vector backbone using PEG precipitation.
Nucleosomes were assembled on these substrates using salt dialysis following published procedures 13, 41 . 50 µl reactions were prepared containing 10 µg of DNA, and histones H2A-H2B and H3-H4 at empirically determined concentrations that varied slightly with each batch Cell-free Xenopus egg extracts. Cytostatic factor (CSF) M phase arrested X. laevis egg extracts were prepared as previously described 46 . Histones H3 and H4 were depleted using antibodies recognizing acetylated lysine 12 on histone H4 using our previously describedmethod 13 µg/ml RNase A [Qiagen]) and incubated at 37 ºC for 25 min. 250 µl of Stop buffer 2 was then added and beads were incubated at 37 ºC for another 25 min. DNA was extracted with phenol/chloroform, precipitated with ethanol/NaOAc, dissolved in 1x TE containing 50 µg/ml RNase A, and incubated at 37 ºC for 20 min before being analysed as above.
In-solution binding assays. Binding reactions contained mononucleosomes or 601 monomers at 20 nM and recombinant cGAS at the concentrations indicated in Fig. 2C in a total of 20 µl of low salt buffer 2 (10 mM Tris-Cl [pH 7 at 22 °C]; 0.25 mM EDTA; 100 mM NaCl; 1 mM TCEP). Reactions were allowed to proceed for 1 h at room temperature. Products were separated by native polyacrylamide gel electrophoresis (5% polyacrylamide in 0.5x TBE). Gels were stained with SYBR-Safe to visualize DNA, and disappearance of the band corresponding to naked DNA or nucleosomes was quantified using ImageJ. Binding affinity was determined with GraphPad Prism (v. 5.0a) using non-linear regression analysis assuming specific one site binding. 20 cGAMP synthesis assays. cGAMP synthesis assays were performed in 20 mM Tris (pH 7.5 at 22 °C), 150 mM NaCl, 1 mM DTT, 10 mM MgCl 2 . Reactions contained 1 µM cGAS and 230 nM mononucleosomes or monomer of naked 601 sequence. cGAS was first pre-incubated with naked DNA or mononucleosomes at room temperature for 30 min. ATP and GTP were then added to a final concentration of 1 mM each to start the reaction. At the same time, GTP labelled at the alpha position with 33 P was also added to a final concentration of 33 nM. Reactions (10 µl total volume) were incubated at 37 °C and 1.5 µl samples were taken at the indicated time points.
Unreacted nucleotides were digested with 4 u alkaline phosphatase (calf intestinal phosphatase, NEB) at 37 °C for 30min, and products were separated via thin-layer chromatography using PEI cellulose F coated sheets (EMD Millipore # 1055790001) with 1.2 M KH 2 PO 4 (pH 3.8) as running buffer. Plates were dried at 65 °C, analysed by fluorometry, and images were quantified using ImageJ. Initial reaction velocities were determined using linear regression analysis of the 10 min, 20 min and 30 min time points. We confirmed that under our conditions, all cGAS molecules were saturated with nucleosomes or DNA by titration experiments. Thus, the values obtained for our initial reaction velocities represent maximum reaction velocities (Vmax). Vmax values were used to determine Kcat values.
Statistics.
Statistical significance was determined with GraphPad Prism (v. 5.0a) using a built-in unpaired t-test function (Fig. 2c, d; Fig. 3b ; Extended Data Fig. 4b ; as determined by F-test, no statistically significant differences in variances existed in any of these cases), or a built-in Mann-Whitney U test function (Fig. 3c , d and f-j; Fig. 4a, b , d, f; Extended Data Fig. 6a, b ). Since mitotic cell death is a stochastic event, data variations are inherit to each cell line and unpredictable, and we therefore empirically determined the sample size that is sufficient to provide statistically significant differences. No statistical tests were used to predetermine sample Extended Data Figure 8 . cGAS expression and cGAMP have only minor effect on ARPE-19 hTERT cells. a and b, ARPE-19 hTERT cells of the indicated type were released from G2 arrest in the presence of taxol and proTAME. Individual cells (n = 30-60 each) were tracked using live-microscopy. c, ARPE-19 hTERT cells of the indicated type were released from G2 arrest in the presence of taxol and proTAME. After three hours, cGAMP was added to 33 µM for the indicated cells. Untr., untreated. Mean and SEM from three experiments (n = 30 each) are shown. d, Western blot analysis of IRF3 phosphorylation following treatment of asynchronous cells with 33 µM cGAMP. 
